Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Edaravone

An antioxidant that neutralises free radicals, used in Japan since 2001 for stroke and later also approved for amyotrophic lateral sclerosis (ALS), in Japan in 2015. This family brings together metabolites, labelled standards and other impurities.

Did you know?In 2017 it became the first new ALS medicine approved by the FDA in 22 years: the previous one was riluzole, in 1995.

Edaravone-d5Isotopically labelledEdaravone-d5Cat. No. P-E008-005CAS 1228765-67-0

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.